EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 21-Sep-2025 16:11 ET (21-Sep-2025 20:11 GMT/UTC)

Being physically active, even just a couple of days a week, may be key to better health

American Heart Association
Peer-Reviewed Publication

A “weekend warrior” approach to physical activity — getting 150 minutes of moderate-to-vigorous physical activity over one to two days instead of throughout the week — improved health and lowered the risk of death, finds a new study in the Journal of the American Heart Association.

Journal: Journal of the American Heart Association

High-fat diet promote breast cancer metastasis in animal models

Centro Nacional de Investigaciones Oncológicas (CNIO)
Peer-Reviewed Publication

CNIO researchers discover that, in mice that eat a lot of fat, cancer cells travelling through the blood surround themselves with platelets, which act as an armor-like protection as they spread.

In addition, in animals with a fatty diet it is easier for tumor cells to 'nest' in other organs and give rise to metastasis of the primary tumor.

“These results anticipate a future in which dietary changes, together with the control of platelet activity, will complement antitumor treatments,” says Héctor Peinado, of the Spanish National Cancer Research Center (CNIO).

The study is published in 'Nature Communications’.

Journal: Nature Communications
Funder: Worldwide Cancer Research, Agencia Estatal de Investigación, WHRI-ACADEMY, “la Caixa” Foundation, Spanish National Research and Development Plan, Instituto de Salud Carlos III, Fundación Científica Asociación Española Contra el Cáncer

Gold battles cancer

Wiley
Peer-Reviewed Publication

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has begun to focus on gold. In the journal Angewandte Chemie, a French research team has now published the first study about the speciation and distribution of an organogold(III) complex in cancer cells and reveals how specially designed “organogold” complexes might open exciting avenues for fighting cancer.

Journal: Angewandte Chemie International Edition
Funder: Sorbonne Université, Université Grenoble Alpes, Inserm, Agence Nationale de la Recherche, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale

AI-driven smart devices to transform healthcare

University of Technology Sydney
Peer-Reviewed Publication

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare, a new study suggests.

Journal: Results in Engineering

KAIST Develops Retinal Therapy to Restore Lost Vision

The Korea Advanced Institute of Science and Technology (KAIST)
Peer-Reviewed Publication

KAIST researchers have successfully developed a novel drug to restore vision.

Journal: Nature Communications
Funder: National Research Foundation of Korea, Korea Drug Development Foundation

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

The University of Texas at San Antonio Health Science Center
Peer-Reviewed Publication

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly blood cancer with a five-year survival rate of just 30%, according to the National Cancer Institute. Their study, published in Cell Stem Cell in February, highlights the crucial role of a protein called paraspeckle component 1 (PSPC1) in the progression of AML.

Journal: Cell Stem Cell

Study examines lactation in critically ill patients

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

Recent research from the University of Michigan reveals that simple awareness on the part of the care team can help protect the breastfeeding relationship for patients in the ICU.

Journal: CHEST Critical Care

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

University of Virginia School of Engineering and Applied Science
Grant and Award Announcement

The 2025 Pierre Galletti Award, the American Institute for Medical and Biological Engineering’s highest award, was given on March 30 to Jennifer L. West, dean of the UVA School of Engineering and Applied Science.

Blood cancer patients taking Bruton Tyrosine Kinase inhibitors should continue treatment at the time of COVID-19 vaccination, study shows

University of Birmingham
Peer-Reviewed Publication

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study published in the Lancet Haematology suggests.

Journal: The Lancet Haematology

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

Peking University
Peer-Reviewed Publication

Peking University, March 31, 2025: Professor Zeng Zexian’s team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua University Joint Center for Life Sciences, has developed ICRAFT, an innovative computational platform for identifying cancer immunotherapy targets. Their study has been published in Immunity, an immunology research journal.

Journal: Immunity